Ingevity price target raised to $65 from $60 at Wells Fargo
Wells Fargo raised the firm’s price target on Ingevity (NGVT) to $65 from $60 and keeps an Equal Weight rating on the shares. The firm is adjusting its estimates for Ingevity to account for the sale of the majority of its Industrial Specialties business, which closed on January 5. Wells stays on the sidelines given uncertainty as Ingevity explores alternatives for other businesses.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NGVT:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.